'Need assurance on quality of generic medicines; we have alerted govt'

Indian Medical Association (IMA) president Dr Sharad Agarwal has raised concerns over the quality of generic medicine made in India. In an interview, he also raised concerns on restrictions placed on doctors attending medical conferences, saying educational conferences are only a discussion forum about advancements in medicine.

- Priyanka Sharma

His remarks come amid a controversy on a National Medical Commission (NMC) regulations, now put on hold by the health ministry.

Edited excerpts:

What is IMA’s response to the new regulations?

The biggest concern is quality of generic medicines in India -- because there is no control and quality check on it. We have urged to the government that generic drugs being manufactured in India should hit the market through proper channel following all regulatory compliance. We (doctors) cannot prescribe medicine in the name of ‘cheap medicine’ if the medicine is not effective. During the meeting with the health ministry last week, we raised our concern about the generic drugs and its quality.